Vitality Biopharma, Inc. announced earnings results for the second quarter ended September 30, 2020. For the second quarter, the company announced operating loss was USD 473,119 compared to USD 1.021 million a year ago. Net loss was USD 472,932 compared to USD 1.227 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.02 a year ago. For the half year, operating loss was USD 1.213 million compared to USD 2.210 million a year ago. Net loss was USD 1.213 million compared to USD 2.818 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.04 a year ago.